Past Medical History:  - MI s/p cardiac catheterization and stenting, [**2138**]  - HTN - Alcohol abuse - Hx anterior cervical spinal fusion   Social History: EtOH abuse, 40 pack year smoking history  Family History: There is no family history of premature coronary artery disease or sudden death, DM, HTN.
Pertinent Results: ADMISSION LABS:  [**2143-7-23**] 10:35PM   PLT SMR-VERY LOW PLT COUNT-63*# [**2143-7-23**] 10:35PM   PT-8.5* PTT-30.3 INR(PT)-0.8* [**2143-7-23**] 10:35PM   WBC-8.5 RBC-4.43* HGB-15.3 HCT-44.0 MCV-99* MCH-34.5* MCHC-34.8 RDW-14.9 [**2143-7-23**] 10:35PM   ASA-NEG ETHANOL-365* ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2143-7-23**] 10:35PM   GLUCOSE-96 UREA N-17 CREAT-0.7 SODIUM-135 POTASSIUM-3.7 CHLORIDE-93* TOTAL CO2-20* ANION GAP-26* [**2143-7-25**] 03:59AM BLOOD ALT-84* AST-69* AlkPhos-101 TotBili-1.0  STUDIES:  [**7-23**] CT head 1.
Partially imaged is an anterior cervical fusion device.
He was admitted to the neurosurgical ICU for q4H neuro checks and SBP control < 140.
He did not require surgical intervention.
Patient was started on Keppra for seizure prophylaxis.
Heparin-based products were held and patient received pneumoboots for DVT prophylaxis.
His platelets trended up to 120's upon discharge without intervention, and he was counseled extensively on alcohol cessation and the risk of recurrent bone marrow suppression should he continue to drink.
ETOH abuse: Patient was maintained on CIWA protocol, requiring up to 40mg IV ativan on [**2143-7-26**].
He was counseled extensively on the implications of his EtOH use and the importance of pursuing outpatient treatment and enrolling in AA.
He declined inpatient rehab placement but was provided with a list of day treatment programs and planned to take a month off from work to dedicate himself to sobriety.
Incidental CT finding: On [**7-23**] CT C-spine, lucency was noted near screws of anterior cervical fusions, read as possible loosening.
HLD: Patient was continued on atorvastatin  2.
HTN: Patient was continued on metoprolol and lisinopril with goal SBP <140 as per neurosurgery recommendations.
Depression: Patient was continued on escitalopram  TRANSITIONAL ISSUES: - Monitor for new neurological deficits and follow up head CT to ensure improvement - Trend platelets - Follow up alcohol cessation - Follow-up CT for incidental 5mm RLL lung nodule in 6 months - Continue to monitor for signs of instability at anterior cervical fusion site  Medications on Admission: .
Metoprolol Tartrate 12.5 mg PO BID 2.
Escitalopram Oxalate 20 mg PO DAILY 3.
Lisinopril 2.5 mg PO DAILY 4.
Atorvastatin 40 mg PO DAILY   Discharge Medications: 1.
Atorvastatin 40 mg PO DAILY 2.
Escitalopram Oxalate 20 mg PO DAILY 3.
Lisinopril 2.5 mg PO DAILY 4.
Metoprolol Tartrate 12.5 mg PO BID 5.
FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 6.
LeVETiracetam 500 mg PO BID RX *Keppra 500 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*2 7.
Multivitamins 1 TAB PO DAILY RX *Daily Multi-Vitamin   1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8.
Nicotine Patch 21 mg TD DAILY RX *Nicoderm CQ 21 mg/24 hour Wear on patch once a day Disp #*14 Unit Refills:*0 9.
Thiamine 100 mg PO DAILY RX *thiamine HCl 100 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0   Discharge Disposition: Home  Discharge Diagnosis: Intracranial hemorrahge Thrombocytopenia Alcohol withdrawal   Discharge Condition: Mental Status: Clear and coherent.
Your bleed was monitored and you were treated for alcohol withdrawal.
Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc.
